GE HealthCare (NASDAQ: GEHC) reported mixed Q3 2024 results, beating EPS expectations at $1.14 but falling short on revenue with $4.86 billion. Shares dipped 1% premarket. The company raised its annual EPS guidance, signaling potential growth despite market challenges.